Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K

March 31, 2023

SAN DIEGO, CA, March 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB:SIGY) (“Sigyn Therapeutics” or the “Company”), a development-stage company that creates blood purification technologies to address unmet needs in global health, announced today the filing of its Form 10-K annual report with the United States Securities and Exchange Commission (“SEC”) for the year ended December 31, 2022. 

Read more at globenewswire.com

Related news for (SIGY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.